Keros Therapeutics, Inc. (KROS)
NASDAQ·Healthcare·Biotechnology
$11.38
+3.36%
Mkt Cap $428.42M
Analyst Ratings
Buy
3
Hold
2
Sell
0
Price Target (7 analysts)
$102.60
Range $96.00 – $107.00
Implied Upside
+801.6%
Consensus $102.60 vs current $11.38
NASDAQ·Healthcare·Biotechnology
$11.38
+3.36%
Mkt Cap $428.42M
Buy
3
Hold
2
Sell
0
Price Target (7 analysts)
$102.60
Range $96.00 – $107.00
+801.6%
Consensus $102.60 vs current $11.38